Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04218422 · ClinicalTrials.gov registry record · NA
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
A NA study of Hidradenitis Suppurativa, sponsored by Wayne State University.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT04218422: Recruiting NA study of Hidradenitis Suppurativa, sponsored by Wayne State University.
NCT04218422 is a NA study of Hidradenitis Suppurativa that is actively recruiting participants, run by Wayne State University. The registered enrollment target is 32 participants, below the 597-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04218422, a NA study of Hidradenitis Suppurativa, is actively recruiting participants, sponsored by Wayne State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.
Primary Outcome
Difference in Average Patient self-reported Pain Numerical Rating Score from 0-10, comparing average from 2 weeks prior to treatment with average from 2 weeks after treatment
Conditions Studied
Interventions
- PROCEDURE Sham Acupuncture
- PROCEDURE Battlefield Acupuncture
Study Locations (1)
Michigan
- WSUPG Dermatology - Dearborn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2031-02-20 |
| Phase | NA |
What NCT04218422 shows while recruiting
NCT04218422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 597-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 2 interventions - of which Sham Acupuncture is the first listed.
NCT04218422 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04218422 about?
NCT04218422 is a clinical study titled "Battlefield Acupuncture for Pain in Hidradenitis Suppurativa". The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.
What is the current status of trial NCT04218422?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2020-01-22. Estimated completion is 2031-02-20.
What conditions does trial NCT04218422 study?
This clinical trial studies the following conditions: Hidradenitis Suppurativa.
What interventions are being tested in trial NCT04218422?
The interventions under investigation include: Sham Acupuncture (PROCEDURE), Battlefield Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT04218422?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04218422 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hidradenitis Suppurativa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04218422's enrollment target sits among peer trials
32 37th of 52 higher than 16 of 52 other Hidradenitis Suppurativa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hidradenitis Suppurativa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Aviclear for Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Physical Activity in Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
RECRUITING · NA
-
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
COMPLETED · NA
-
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
COMPLETED · NA
-
Hidradenitis Suppurativa (HS) Tunneling Wounds
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI